![Gianluca Pirozzi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gianluca Pirozzi
Conseiller Juridique Général chez
ALEXION PHARMACEUTICALS, INC.
Profil
Gianluca Pirozzi currently works at Alexion Pharmaceuticals, Inc., as Senior VP, Head-Development, Regulatory & Safety from 2023.
Dr. Pirozzi also formerly worked at Trex Wind-down, Inc., as Independent Director from 2020 to 2024, Imbria Pharmaceuticals, Inc., as Director from 2018 to 2020, Genzyme Corp., as Head-Rare Diseases from 2018 to 2019, Genzyme Therapeutics Ltd., as Head-Gene Therapy, and Sanofi, as Head-Development for Rare Diseases & Gene Therapy from 2018 to 2019.
Dr. Pirozzi received his doctorate degree from Sapienza University of Rome and doctorate degree from Università Campus Bio-Medico di Roma.
Postes actifs de Gianluca Pirozzi
| Sociétés | Poste | Début |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/10/2019 |
Anciens postes connus de Gianluca Pirozzi
| Sociétés | Poste | Fin |
|---|---|---|
| TREX WIND-DOWN, INC. | Directeur/Membre du Conseil | 01/05/2024 |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Directeur/Membre du Conseil | 01/05/2020 |
| SANOFI | Corporate Officer/Principal | 01/09/2019 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | - |
Formation de Gianluca Pirozzi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Sapienza University of Rome
 Sapienza University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Università Campus Bio-Medico di Roma
 Università Campus Bio-Medico di Roma Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imbria Pharmaceuticals, Inc.
Imbria Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company for the treatment of cardiovascular disease | Commercial Services |
Timber Pharmaceuticals, Inc.
 Timber Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes therapies for treatment of orphan dermatologic diseases | Health Technology |
